Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$877M |
| 2 |
Booking.com
BKNG
|
+$370M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$329M |
| 4 |
Boeing
BA
|
+$303M |
| 5 |
Walmart Inc
WMT
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$544M |
| 2 |
iShares MBS ETF
MBB
|
+$461M |
| 3 |
NVIDIA
NVDA
|
+$452M |
| 4 |
T-Mobile US
TMUS
|
+$426M |
| 5 |
Apple
AAPL
|
+$408M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.15% |
| 2 | Healthcare | 3.06% |
| 3 | Financials | 2.35% |
| 4 | Consumer Discretionary | 2.28% |
| 5 | Industrials | 1.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6226
PUT
Sprout Social
SPT
$579M
| $2.19M | ﹤0.01% |
24,500
-3,400
| -12% | -$236K |
|
6227
CALL
West Pharmaceutical
WST
$24.4B
| $2.19M | ﹤0.01% |
6,100
-1,000
| -14% | -$330K |
|
6228
CALL
Voya Financial
VOYA
$9.2B
| $2.19M | ﹤0.01% |
35,600
-47,600
| -57% | -$3.13M |
|
|
BBIG
6229
CALL
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $2.19M | ﹤0.01% |
40,734
+36,581
| +881% | +$1.57M |
|
|
OPI
6230
CALL
DELISTED
Office Properties Income Trust
OPI
| $2.19M | ﹤0.01% |
74,600
+26,600
| +55% | +$762K |
|
6231
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.44B
| $2.19M | ﹤0.01% |
58,249
-326,909
| -85% | -$12.2M |
|
6232
PUT
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $2.19M | ﹤0.01% |
81,800
-4,900
| -6% | -$133K |
|
6233
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10B
| $2.19M | ﹤0.01% |
+67,778
| New | +$2.16M |
|
6234
PUT
Ryder
R
$10.1B
| $2.19M | ﹤0.01% |
29,400
+5,400
| +23% | +$427K |
|
6235
CALL
Barclays
BCS
$93.6B
| $2.18M | ﹤0.01% |
226,300
-71,300
| -24% | -$728K |
|
6236
Dimensional US Targeted Value ETF
DFAT
$15B
| $2.18M | ﹤0.01% |
+48,751
| New | +$2.19M |
|
|
ICPT
6237
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.18M | ﹤0.01% |
109,300
+1,600
| +1% | +$31.7K |
|
|
AHT
6238
PUT
Ashford Hospitality Trust
AHT
$20.8M
| $2.18M | ﹤0.01% |
4,782
+1,564
| +49% | +$567K |
|
|
NGCAU
6239
DELISTED
NextGen Acquisition Corp. II Units
NGCAU
| $2.18M | ﹤0.01% |
201,526
-1,998,474
| -91% | -$20.2M |
|
6240
PUT
Prothena Corp
PRTA
$455M
| $2.18M | ﹤0.01% |
42,400
+8,000
| +23% | +$250K |
|
|
GTT
6241
PUT
DELISTED
GTT Communications, Inc.
GTT
| $2.18M | ﹤0.01% |
896,700
+870,700
| +3,349% | +$1.69M |
|
6242
Karyopharm Therapeutics
KPTI
$41.1M
| $2.18M | ﹤0.01% |
14,073
-40,761
| -74% | -$5.92M |
|
6243
Adient
ADNT
$1.57B
| $2.18M | ﹤0.01% |
48,171
+27,104
| +129% | +$1.27M |
|
6244
Anika Therapeutics
ANIK
$288M
| $2.18M | ﹤0.01% |
50,284
+30,300
| +152% | +$1.29M |
|
|
BLD
6245
PUT
DELISTED
TopBuild
BLD
| $2.18M | ﹤0.01% |
11,000
+3,900
| +55% | +$808K |
|
6246
CALL
Global X Cloud Computing ETF
CLOU
$350M
| $2.18M | ﹤0.01% |
76,200
-91,000
| -54% | -$2.43M |
|
6247
CALL
Camden Property Trust
CPT
$11.1B
| $2.18M | ﹤0.01% |
16,400
+8,300
| +102% | +$1.03M |
|
6248
CALL
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.7B
| $2.17M | ﹤0.01% |
47,000
-49,000
| -51% | -$2.16M |
|
|
MIME
6249
CALL
DELISTED
Mimecast Limited
MIME
| $2.17M | ﹤0.01% |
41,000
+17,300
| +73% | +$813K |
|
6250
Monte Rosa Therapeutics
GLUE
$1.31B
| $2.17M | ﹤0.01% |
+95,792
| New | +$1.95M |
|
Similar funds
Ken Griffin's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
- Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
- Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
- Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
- Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
- Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
- Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.